Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Lili Cao is active.

Publication


Featured researches published by Lili Cao.


Cancer Letters | 2008

Acquisition of anoikis resistance reveals a synoikis-like survival style in BEL7402 hepatoma cells.

Zhiyong Zhang; Lili Cao; Jie Li; Xiaohong Liang; Yugang Liu; Hua Liu; Juan Du; Zhonghua Qu; Min Cui; Suxia Liu; Lifen Gao; Chunhong Ma; Lining Zhang; Lihui Han; Wensheng Sun

Resistance to anoikis is a hallmark of human malignancies. Our results showed that hepatoma cells resisted anoikis by non-proliferation, non-apoptosis and cell cycle arrest which were termed synoikis-like. These synoikis-like cells are more resistant to extracellular stimuli and could spontaneously attach and proliferate again under suitable conditions, which indicate a reversible property of these cells. Microarray expression profile reveals the change of molecules involved in the synoikis-like hepatoma cells and our data indicated that ANGPTL4 contributed to anoikis resistance of hepatoma cells. These results demonstrated that hepatoma cells might resist anoikis through a synoikis-like survival style, which may facilitate tumor metastasis.


Folia Histochemica Et Cytobiologica | 2008

Aggregation formation mediated anoikis resistance of BEL7402 hepatoma cells.

Zhiyong Zhang; Lihui Han; Lili Cao; Xiaohong Liang; Yugang Liu; Hua Liu; Juan Du; Zhonghua Qu; Changjun Zhu; Suxia Liu; Hui Li; Wensheng Sun

Anoikis resistance is the prerequisite of cancer cells metastasis. Elucidation of the mechanism of anoikis resistance remains a significant challenge. We reported here a model to mimic anoikis resistant process of hepatoma cells in vitro. Experimental results indicated cell to cell aggregation could mediate anoikis resistance of BEL7402 hepatoma cells. Further investigation of these aggregations indicated the biological properties changed greatly after the hepatoma cells lost their anchorage. Aggregation forming process could be separated into three distinct phases according to their biological characteristics, comprising of premature phase, mature phase and postmature phase. Mature phase aggregations have the premium state of cell viability and may mimic the metastatic cells in the circulating system. Biological properties of these three phases aggregations were studied in details including morphological alteration, cell viability and microarray expression profiles. It indicated there was a great upregulation of adhesion molecules during the process of aggregation formation and the cell to cell contact in the aggregation may be mediated independent of calcium involved adhesion pathway. This model might shed light on the anoikis resistance mechanism of hepatoma cells and help to develop new therapies that may target the anoikis resistant hepatoma cells in the metastasis process.


Biochemical and Biophysical Research Communications | 2008

Blockade of preS2 down-regulates the apoptosis of HepG2.2.15 cells induced by TRAIL☆

Xiaohong Liang; Zhonghua Qu; Zhiyong Zhang; Juan Du; Yugang Liu; Min Cui; Hua Liu; Lifen Gao; Lihui Han; Suxia Liu; Lili Cao; Peiqing Zhao; Wensheng Sun

The TNF-related apoptosis-inducing ligand (TRAIL) has recently been implicated in the death of hepatocytes under infectious but not normal conditions. Our previous studies showed that both the whole HBV genome and its HBx protein enhanced TRAIL-induced hepatocyte apoptosis. We report here that preS2-containing viral proteins are also potent regulators of TRAIL-induced apoptosis. HBV-transfected hepatoma cell line, HepG2.2.15, pretreated with antisense oligonucleotide against preS2 gene, showed a lower sensitivity towards TRAIL-induced apoptosis. However, this effect might not be related with the expression level of TRAIL receptors. These results establish that besides HBx, preS2 viral proteins are also involved in enhancing TRAIL-induced hepatocyte apoptosis. The novel role of preS2 would be useful to further unravel the mechanisms of imbalanced apoptosis during HBV infection and provides a potential therapeutic target for HBV-related diseases.


Molecular Medicine Reports | 2014

Mitogen-activated protein kinase pathway is pivotal for anoikis resistance in metastatic hepatoma cells

Lili Cao; Zhiyong Zhang; Lihui Han; Juan Du; Xiaohong Liang; Yugang Liu; Wensheng Sun

It is important for metastatic cancer cells to acquire anoikis resistance for survival in the circulatory system. In the present study, metastatic hepatoma cells were demonstrated to acquire anoikis resistance, which renders them more invasive, more resistant to anticancer agents and able to evade the host immune system for long‑term survival. One of the most significant characteristics of these anoikis‑resistant metastatic hepatoma cells is their proliferation inhibition. However, when microarray results were analyzed to identify the underlying molecular mechanism, the mitogen‑activated protein kinase (MAPK) signaling pathway was found to be markedly upregulated, which appeared to conflict with the proliferation inhibition state. To investigate this result and the associated mechanism, protein kinase inhibitors were used to inhibit the phosphatidylinositol 3‑kinase (PI-3K)/AKT and MAPK pathways. It was found that anoikis-resistant hepatoma cells may compensate for the inhibition of PI-3K/AKT or MAPK pathways by cross-talk between these two pathways, which increases their survival capacity during metastasis. In concordance with this result, western blot analysis revealed that the phosphorylation level of extracellular signal‑related kinase protein was increased when the PI-3K/AKT pathway was inhibited. Therefore, it was concluded that when metastatic hepatoma cells aggregate in blood vessels, proliferation is inhibited and the MAPK signaling pathway is upregulated, which increases the long‑term survival of the cells. Furthermore, a compensatory interplay between the AKT and MAPK signaling pathways was observed in the present study. Using kinase inhibitors for the two pathways in combination may yield a substantial advance in successfully producing a downstream phenotypic response in anoikis‑resistant metastatic hepatoma cells.


Molecular Biology Reports | 2009

A PCR based method to construct small interference RNA expression vectors.

Zhiyong Zhang; Lihui Han; Xiaohong Liang; Lili Cao; Wensheng Sun

Small interference RNAs (siRNA) have been shown to be useful in the field of gene therapy and gene function studies. As a siRNA expression vector, pSilencer employ RNA polymerase III promoters and could stably produce siRNA for weeks. But once one siRNA sequence was inserted into the pSilencer vector, the other siRNA sequence will hardly be reconstructed, because the site of siRNA production has been occupied and difficult to be changed, so it is not suitable for screen of effective siRNA sequence. To solve this problem, we constructed the subclone pSilcencer329, which generated from pSilencer3.1, then developed a PCR based method of constructing siRNA expression vectors, and generated pSilencerBCL2L2 recombinants efficiently. This method was proven to be effective, reliable, and less expensive, and thus will be of great help in regular gene silencing studies, and will be especially suitable for large scale gene function analysis.


Experimental Cell Research | 2009

Involvement of anoikis-resistance in the metastasis of hepatoma cells.

Lili Cao; Lihui Han; Zhiyong Zhang; Jie Li; Zhonghua Qu; Juan Du; Xiaohong Liang; Yugang Liu; Hua Liu; Yongyu Shi; Suxia Liu; Lifen Gao; Wensheng Sun


Archive | 2007

A siRNA and expression carrier capable of inhibiting Bax gene expression and application of the same used as virus hepatitis B treatment medicament

Wensheng Sun; Xiaohong Liang; Yugang Liu; Min Cui; Lili Cao; Nan Hou; Tian Ma; Juan Du; Zhonghua Qu; Hua Liu; Zhiyong Zhang


Archive | 2010

Method for acquiring solid tumor cell with successful in-vitro transfection

Lili Cao; Juan Du; Lifen Gao; Lihui Han; Xiaohong Liang; Suxia Liu; Yugang Liu; Zhonghua Qu; Yongyu Shi; Wensheng Sun; Zhiyong Zhang


Archive | 2008

Vitro model capable of Dynamic modeling human cancer of liver displace

Wensheng Sun; Lihui Han; Zhiyong Zhang; Lili Cao; Xiaohong Liang; Zhonghua Qu; Juan Du; Tian Ma; Nan Hou; Chun Guo; Yugang Liu


Archive | 2008

Method for quickly constructing siRNA carrier by using pSilencer plasmid

Wensheng Sun; Zhiyong Zhang; Lihui Han; Lili Cao; Ying Ju; Juan Du; Tian Ma; Nan Hou; Zhonghua Qu; Yugang Liu; Min Cui; Xiaohong Liang

Collaboration


Dive into the Lili Cao's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge